Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Nucleic Acid Therapeutics CDMO Market to Reach $14.19 Billion by 2033 – BIS Research Market Intelligence Report
Global Nucleic Acid Therapeutics CDMO Market to Reach $14.19 Billion by 2033 – BIS Research Market Intelligence Report
Opaleye Management Inc. lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 957,500 shares of the biotechnology company’s stock after selling 197,500 shares during the quarter. Codexis makes up […]
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Tuesday. Other equities research analysts also recently issued research reports about the company. HC Wainwright downgraded Codexis from a buy rating to a neutral rating in a report on Tuesday, […]
The rapidly increasing prevalence of chronic diseases around the world is likely to fuel the demand for novel medications and better treatment options, propelling the worldwide market forward. Because of the increased desire for novel treatment options, there has been an increase in the use of drug intermediates as...